title: Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies.
abstract: BACKGROUND
  Obese patients with type 2 diabetes undergoing bariatric surgery experience significant and lasting weight loss and improved glycaemic control. However, bariatric surgical procedures such as Roux-en-Y gastric bypass are irreversible and associated with considerable short-term and long-term risks. The EndoBarrier Gastrointestinal Liner or duodenal-jejunal bypass sleeve (DJBS) is a fully reversible procedure that has been developed to treat obesity and type 2 diabetes. We aim to perform a systematic review and meta-analysis of safety and efficacy of DJBS.
  
  
  METHODS
  A systematic review with meta-analysis (as per the preferred reporting items for systematic reviews and meta-analyses) of randomised controlled trials of the device (vs no intervention, sham and/or low-calorie diet) will be performed. Primary endpoints include change in body weight and glycated haemoglobin and safety. Secondary endpoints constitute changes in other glycaemic parameters and blood lipids and the proportion of patients discontinuing antidiabetic medication. MEDLINE, EMBASE, The Cochrane Library and Science Citation Index will be sought electronically along with manual searches. The primary meta-analysis will use random effects models due to an expected intertrial heterogeneity. Fixed effect meta-analysis will be executed to assess the impact of small trials. Dichotomous data will be analysed using risk difference and continuous data using weighted mean differences, both with 95% CIs.
  
  
  BACKGROUND
  The study will describe the impact of DJBS on obesity and type 2 diabetes and possibly contribute to clinical decision-making. The results of this study will be disseminated by peer-reviewed publication and scientific presentations.
  
  
  BACKGROUND
  PROSPERO CRD42013004819.
authors.affiliation: Diabetes Research Division, Department of Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Rohde
authors.forename: Nora
authors.initials: N
authors.lastname: Hedbäck
authors.forename: Lise L
authors.initials: LL
authors.lastname: Gluud
authors.forename: Tina
authors.initials: T
authors.lastname: Vilsbøll
authors.forename: Filip K
authors.initials: FK
authors.lastname: Knop
keywords: DIABETES & ENDOCRINOLOGY
references.citation: Surgery. 2007 Oct;142(4):621-32; discussion 632-5
references.pmid: 17950357
references.citation: Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
references.pmid: 19622511
references.citation: Diabetologia. 2012 Jun;55(6):1577-96
references.pmid: 22526604
references.citation: Diabetes Technol Ther. 2009 Nov;11(11):725-32
references.pmid: 19905889
references.citation: Surg Endosc. 2008 Mar;22(3):772-6
references.pmid: 18270770
references.citation: Diabetologia. 2009 Nov;52(11):2270-2276
references.pmid: 19727661
references.citation: Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:2501-3
references.pmid: 19163211
references.citation: Obes Surg. 2013 Sep;23(9):1354-60
references.pmid: 23526068
references.citation: Diabetologia. 2012 Jul;55(7):1890-901
references.pmid: 22538359
references.citation: Ann Surg. 2010 Feb;251(2):236-43
references.pmid: 19858703
references.citation: JAMA. 2004 Oct 13;292(14):1724-37
references.pmid: 15479938
references.citation: Gastrointest Endosc. 2010 May;71(6):976-82
references.pmid: 20304396
references.citation: Surg Endosc. 2009 Mar;23(3):650-6
references.pmid: 19067075
references.citation: Nat Rev Endocrinol. 2012 Sep;8(9):544-56
references.pmid: 22525731